Mar 26 2018
Business Insider featured Auris’s Monarch Platform, including an animation of what happens during a bronchoscopy procedure. The article also notes that the Monarch Platform integrates the latest advancements in robotics, software, data science, and endoscope innovation, saying “Auris’s newest platform, called Monarch, is designed with the intent of transforming endoscopy, particularly in the field of lung cancer diagnosis.”
Auris aims to help diagnose lung cancer in the early stages, which is critical to battling the disease. Currently, over 90% of those diagnosed with lung cancer do not survive because the cancer is typically discovered in the advanced, inoperable stages. Auris CSO Josh DeFonzo discusses future plans for the Monarch Platform in the article, saying, “We believe that Monarch will become the go-to approach for diagnosing lung cancer in the future.”
Ultimately, the goal of the Monarch Platform is to dramatically improve patient outcomes in a field that has seen few major advances since the 1960s. Auris believes the Monarch Platform will enhance physician capabilities and lower costs to the healthcare system. The Monarch Platform allows clinicians to maneuver cameras within the patient’s body with great precision, even in difficult-to-access areas. This may eliminate the need for more invasive procedures.
The article also explains Auris’ strategy behind keeping quiet about their innovative technology over the past six years. “We didn't want to make a big stink until we had a produced a technology that actually solved a problem," said Auris Health board member Peter Hébert.
Hébert also believes that Auris will lead the next phase of surgical robotics intervention. Despite their under-the-radar strategy, Auris has raised $500 million in funding from investors, including Lux Capital, Mithril Capital Management, Highland Capital, and Coatue Management.